The Neurology Minute® podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology® journals, Neurology Today®, Continuum®, and more.
A neurology refresher for first seizure, recurrent seizures and transient loss of awareness. It separates unprovoked, reflex and acutely provoked seizures, then links epilepsy diagnosis to two unprovoked events, high recurrence risk after one event, EEG, imaging and clinical semiology.
Neurology, cardiology and nephrology readers get a concise amyloid-neuropathy red-flag update. Progressive neuropathy should trigger review for orthostatic hypotension, cardiomyopathy, proteinuria, weight loss, bruising, purpura, anasarca, gait decline and ankle weakness rather than limb symptoms alone.
Neurology and critical-appraisal readers get a concise myasthenia gravis testing update. Acetylcholine receptor and MuSK antibodies remain the core serological tests, while LRP4 IgG is uncommon and inconsistently detected, so suspected double-seronegative disease still needs clinical pattern recognition, electrophysiology and reconsideration of alternatives.
Stroke teams and critical-appraisal readers get a focused TAPIS trial update on early aspirin plus ticagrelor after intravenous thrombolysis. The episode keeps NIHSS 4–10 selection, 90-day modified Rankin 0–1 outcomes, symptomatic intracranial haemorrhage and protocol caution together.
Neurology, emergency medicine and radiology teams get a concise appraisal of very-late thrombectomy in large vessel occlusion stroke. The episode keeps last known well, deficit severity, perfusion mismatch, infarct core, collateral status, functional outcome, symptomatic haemorrhage and mortality in the same decision frame.
Neurology and critical-appraisal listeneres get a concise phase 3 trial update in relapsing MOG antibody-associated disease. The blinded, placebo-controlled study reports an approximately 68% reduction in relapses over about two years, while emphasising that a relative treatment effect does not guarantee an individual response or immediate implementation.
Neurology trainees and educators get a concise professional-development item on translating online learning into clinical practice. Diverse case exposure can support pattern recognition and professional identity formation when new approaches are checked against patient context, evidence, local standards and supervision.
Neurology and critical-appraisal readers get a concise lesson in interpreting claims-based access data. Coded encounters can estimate waiting intervals, but they do not confirm referral dates, urgency, rural access or the subspecialty expertise of the neurologist providing care.
Neurology trainees and medical educators get a concise professional-development item on virtual communities and professional identity formation. Purposeful online engagement may move into real-world mentorship, research collaborations, publications and conference presentations.
Clinicians arranging neurology follow-up get a concise lesson in interpreting access data. A wide gap between median and mean waiting times signals a skewed distribution with prolonged delays for some patients, making referral urgency, deterioration advice and routes back into care clinically important.
.svg)